Menu
 
Research menu
Jump to menu

Publications:  Prof Farida Fortune Cbe

Houacine S, Kang A, Parkinson EK, Wan H, Fortune F(2020). Induction of p53 in keratinocyte cultures treated with Behçet's patient sera. Journal of Oral Pathology and Medicine vol. 49, (5) 435-442.
10.1111/jop.13005
https://qmro.qmul.ac.uk/xmlui/handle/123456789/65413
Petrushkin H, Norman PJ, Lougee E, Parham P, Wallace GR, Stanford MR, Fortune F(2019). KIR3DL1/S1 allotypes contribute differentially to the development of Behçet disease. Journal of Immunology vol. 203, (6) 1629-1635.
10.4049/jimmunol.1801178
https://qmro.qmul.ac.uk/xmlui/handle/123456789/63507
Leccese P, Ozguler Y, Christensen R, Esatoglu SN, Bang D, Bodaghi B, Celik AF, Fortune F et al.(2019). Management of skin, mucosa and joint involvement of Behçet's syndrome: A systematic review for update of the EULAR recommendations for the management of Behçet's syndrome. Seminars in Arthritis and Rheumatism vol. 48, (4) 752-762.
10.1016/j.semarthrit.2018.05.008
https://qmro.qmul.ac.uk/xmlui/handle/123456789/50044
Senusi AA, Liu J, Bevec D, Bergmeier LA, Stanford M, Kidd D, Jawad A, Higgins S et al.(2018). Why are Behçet's disease patients always exhausted?. Clin Exp Rheumatol vol. 36, (6 Suppl 115) 53-62.
Senusi A, Higgins S, Fortune F(2018). The influence of oral health and psycho-social well-being on clinical outcomes in Behçet’s disease. Rheumatology International vol. 38, (10) 1873-1883.
10.1007/s00296-018-4117-y
https://qmro.qmul.ac.uk/xmlui/handle/123456789/53203
Ozguler Y, Leccese P, Christensen R, Esatoglu SN, Bang D, Bodaghi B, Çelik AF, Fortune F et al.(2018). Management of major organ involvement of Behçet's syndrome: a systematic review for update of the EULAR recommendations. Rheumatology (Oxford) vol. 57, (12) 2200-2212.
10.1093/rheumatology/key242
https://qmro.qmul.ac.uk/xmlui/handle/123456789/51463
Liu J, Zheng F, Rawlinson SCF, Fortune F, Kim DG(2018). Bone biology and bioactive glass in bone regeneration. Bone Regeneration: Concepts, Clinical Aspects and Future Directions,
Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gul A et al.(2018). 2018 Update of the EULAR recommendations for the management of Behçet's syndrome. Annals of the Rheumatic Diseases vol. 77, (6) 808-818.
10.1136/annrheumdis-2018-213225
https://qmro.qmul.ac.uk/xmlui/handle/123456789/51525
Moots RJ, Fortune F, Situnayake D(2018). The Behçet's centres of excellence: A new paradigm for care delivery in complex diseases. Rheumatology (United Kingdom) vol. 57, (4) 594-595.
10.1093/rheumatology/kex037
Bergmeier LA, Fortune F(2018). Clinical management of oral mucosal disease: A literature Review. Oral Mucosa in Health and Disease: A Concise Handbook,
Bergmeier LA, Fortune F(2018). Non-infectious diseases of the oral mucosa: The importance of immune functions. Oral Mucosa in Health and Disease: A Concise Handbook,
Hasan MS, Ryan PL, Bergmeier LA, Fortune F(2017). Circulating NK cells and their subsets in Behçet's disease. Clinical and Experimental Immunology vol. 188, (2)
10.1111/cei.12939
https://qmro.qmul.ac.uk/xmlui/handle/123456789/19411
Senusi AA, Ola D, Mather J, Mather J, Fortune F(2017). Behçet's syndrome and health-related quality of life: Influence of symptoms, lifestyle and employment status. Clinical and Experimental Rheumatology vol. 35, S43-S50.
Murray-Brown W, Carlotti E, Floyd J, Sutcliffe N, Tappuni A, Vartoukian S, Fortune F, Mehr R et al. (2016). Next-generation sequencing demonstrates dynamic recirculation of B cell clones in ectopic lymphoid structures of Sjogren's syndrome. EUROPEAN JOURNAL OF IMMUNOLOGY. Conference: European League Against Rheumatism vol. 46, 939-940.
https://qmro.qmul.ac.uk/xmlui/handle/123456789/16266
Liu J, Rawlinson S, Hill R, FORTUNE F(2016). Fluoride incorporation in high phosphate containing bioactive glasses and in vitro osteogenic, angiogenic and antibacterial effects. Dental Materials vol. 32, (10) e221-e237.
10.1016/j.dental.2016.07.003
https://qmro.qmul.ac.uk/xmlui/handle/123456789/15386
Petrushkin H, Stanford M, Fortune F, Jawad AS(2016). Clinical Review: Familial Mediterranean Fever—An Overview of Pathogenesis, Symptoms, Ocular Manifestations, and Treatment. Ocular Immunology and Inflammation vol. 24, (4) 422-430.
10.3109/09273948.2015.1010012
https://qmro.qmul.ac.uk/xmlui/handle/123456789/10008
Liu J, Rawlinson SCF, Hill RG, Fortune F(2016). Strontium-substituted bioactive glasses in vitro osteogenic and antibacterial effects. Dental Materials vol. 32, (3) 412-422.
10.1016/j.dental.2015.12.013
https://qmro.qmul.ac.uk/xmlui/handle/123456789/12158
Petrushkin H, Senusi A, Hasan SM, Liu J, Mercadante V, Wakjira N, Kidd D, Buckland M et al. (2016). A SUBGROUP ANALYSIS OF COMORBIDITIES IN BEHCET'S DISEASE; RESULTS FROM A PROSPECTIVE CASE-CONTROLLED STUDY. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. vol. 34, S171-S172.
Pain C, Rice H, Beresford M, Brogan P, Fortune F, Moots R, Murphy R (2016). BRITISH PAEDIATRIC SURVEILLANCE UNIT (BPSU) STUDY OF BEHCET'S SYNDROME IN CHILDREN AND YOUNG PEOPLE IN THE UNITED KINGDOM. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. vol. 34, S157-S157.
Hasan S, Bergmeier LA, Fortune F (2016). CD16+V Delta 2 T CELLS AND THEIR FUNCTIONAL POTENTIAL IN BEHCET'S DISEASE. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. vol. 34, S153-S153.
Situnayake RD, Mitton DL, Murray PI, Damato EM, Carruthers D, Hamburger J, Richards A, Douglas S et al. (2016). ESTABLISHING A NATIONAL SERVICE FOR BEHCET'S SYNDROME IN THE UK - EXPERIENCE OF THE FIRST FOUR YEARS. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. vol. 34, S163-S163.
Bergmeier LA, Malik A, Boukbir N, Hasan S, Fortune F (2016). EXPRESSION OF HOMING MAKERS ON PERIPHERAL BLOOD LYMPHOCYTES IN BEHCET'S DISEASE PATIENTS AND HEALTHY CONTROLS. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. vol. 34, S140-S140.
Petrushkin HJD, Stanford M, Fortune F, Jawad A(2016). Improving morbidity and mortality in peripheral ulcerative keratitis associated with rheumatoid arthritis. Clinical and experimental rheumatology vol. 34, (1) S18-S19.
Petrushkin HJD, Stanford M, Fortune F, Jawad A(2016). Improving morbidity and mortality in peripheral ulcerative keratitis associated with rheumatoid arthritis. Clin Exp Rheumatol vol. 34, (1 Suppl 95) S18-S19.
https://qmro.qmul.ac.uk/xmlui/handle/123456789/11655
Senusi A, Buckland M, Jawad A, Kidd D, Stanford M, Fortune F (2016). THE EFFECT OF MEDICATION ON THE TREATMENT OUTCOMES OF BEHCET DISEASE. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. vol. 34, S186-S187.
Senusi A, Seoudi N, Bergmeier LA, Fortune F(2015). Genital ulcer severity score and genital health quality of life in Behçet's disease Rare systemic diseases. Orphanet Journal of Rare Diseases vol. 10, (1)
10.1186/s13023-015-0341-7
https://qmro.qmul.ac.uk/xmlui/handle/123456789/9183
Murray-Brown W, Carlotti E, Floyd J, Sutcliffe N, Tappuni A, Vartoukian S, Fortune F, Mehr R et al. (2015). NEXT-GENERATION SEQUENCING DEMONSTRATES DYNAMIC RECIRCULATION OF B CELL CLONES IN ECTOPIC LYMPHOID STRUCTURES OF SJOGREN'S SYNDROME. ANNALS OF THE RHEUMATIC DISEASES. vol. 74, 425-426.
10.1136/annrheumdis-2015-eular.2047
Murray-Brown W, Carlotti E, Floyd J, Sutcliffe N, Tappuni A, Vartoukian S, Fortune F, Mehr R et al. (2015). Next-Generation Sequencing Demonstrates Dynamic Recirculation of B Cell Clones in Ectopic Lymphoid Structures of Sjogren's Syndrome. SCANDINAVIAN JOURNAL OF IMMUNOLOGY. vol. 81, 401-402.
https://qmro.qmul.ac.uk/xmlui/handle/123456789/7753
Petrushkin H, Hasan MS, Stanford MR, Fortune F, Wallace GR(2015). Behçet's disease: Do natural killer cells play a significant role?. Frontiers in Immunology vol. 6, (MAR)
10.3389/fimmu.2015.00134
https://qmro.qmul.ac.uk/xmlui/handle/123456789/9188
Hasan MS, Bergmeier LA, Petrushkin H, Fortune F(2015). Gamma Delta (γδ) T Cells and Their Involvement in Behçet's Disease. Journal of Immunology Research vol. 2015,
10.1155/2015/705831
https://qmro.qmul.ac.uk/xmlui/handle/123456789/11649
Seoudi N, Bergmeier LA, Drobniewski F, Paster B, Fortune F(2015). The oral mucosal and salivary microbial community of behçet's syndrome and recurrent aphthous stomatitis. Journal of Oral Microbiology vol. 7, (1) 1-9.
10.3402/jom.v7.27150
https://qmro.qmul.ac.uk/xmlui/handle/123456789/10291
Seoudi N, Bergmeier LA, Hagi-Pavli E, Bibby D, Fortune F(2015). The seroprevalence and salivary shedding of herpesviruses in Behçet's syndrome and recurrent aphthous stomatitis. J Oral Microbiol vol. 7,
10.3402/jom.v7.27156
https://qmro.qmul.ac.uk/xmlui/handle/123456789/7689
Hasan MS, Ryan PL, Bergmeier LA, Fortune F (2014). CD27 distinguishes human NK and V delta 2 cells into distinct subsets in Behcet's disease. IMMUNOLOGY. vol. 143, 113-113.
Bergmeier LA, Hamedi M, Hagi-Pavli E, Seoudi N, Senusi A, Ijaz H, Fortune F (2014). HSP27 as a diagnostic marker in the saliva of Behcet's disease.
https://qmro.qmul.ac.uk/xmlui/handle/123456789/6615
Hasan MDS, Bergmeier LA, Fortune F (2014). Vitamin-D status and its regulation of gamma delta T-cells in Behcet's disease. IMMUNOLOGY. vol. 143, 42-42.
Merashli M, Jawad A, Gokani B, Fortune F(2014). Behcet disease among White British and Mediterranean Ethnicities. ORAL DISEASES vol. 20, 22-22.
Hamedi M, Bergmeier LA, Hagi-Pavli E, VARTOUKIAN SR, Fortune F(2014). Differential expression of Suppressor of Cytokine Signalling proteins in Behçet’s Disease. Scandinavian Journal of Immunology vol. 80, (5) 369-376.
10.1111/sji.12211
VARTOUKIAN SR, Tilakaratne W, Seoudi N, Bombardieri M, Bergmeier L, Tappuni A, Fortune F(2014). Dysregulation of the SOCS3-STAT3 pathway in the aetio-pathogenesis of Sjögren’s syndrome. Clinical and Experimental Immunology vol. 177, (3) 618-629.
10.1111/cei.12377
https://qmro.qmul.ac.uk/xmlui/handle/123456789/7817
Gokani B, Merashli M, Fortune F(2014). Impact of biologic therapies for behcets disease. ORAL DISEASES vol. 20, 20-21.
Fortune F(2014). The clinical presentation of Behcet's disease - why is diagnosis so often delayed?. ORAL DISEASES vol. 20, 2-2.
Zou L, Adegun OK, Willis A, Fortune F(2014). Facial biometrics of peri-oral changes in Crohn's disease. Lasers Med Sci vol. 29, (3) 869-874.
10.1007/s10103-013-1286-5
Seoudi N, Bergmeier LA, Hagi-Pavli E, Bibby D, Curtis MA, Fortune F(2014). The role of TLR2 and 4 in Behçet's disease pathogenesis. Innate Immun vol. 20, (4) 412-422.
10.1177/1753425913498042
https://qmro.qmul.ac.uk/xmlui/handle/123456789/7813
Wright D, Muirhead V, Weston-Price S, Fortune F(2014). Type 2 diabetes risk screening in dental practice settings: A pilot study. British Dental Journal vol. 216, (7)
10.1038/sj.bdj.2014.250
Needleman I, Ashley P, Petrie A, Fortune F, Turner W, Jones J, Niggli J, Engebretsen L et al.(2014). Oral health and impact on performance of athletes participating in the london 2012 olympic games. Br J Sports Med vol. 48, (7) 644-645.
10.1136/bjsports-2014-093494.224
Preshaw P(2014). Summary of: type 2 diabetes risk screening in dental practice settings: a pilot study. Br Dent J vol. 216, (7) 416-417.
10.1038/sj.bdj.2014.263
Gadhia T, Adegun OK, Fortune F(2014). Brown tumours: Widespread involvement of multiple maxillofacial bones and cervical spine. BMJ Case Reports vol. 2014,
10.1136/bcr-2014-207140
Zou L, Adegun OK, Willis A, Fortune F(2014). Facial biometrics of peri-oral changes in Crohn's disease. Lasers in Medical Science vol. 29, (3) 869-874.
10.1007/s10103-013-1286-5
https://qmro.qmul.ac.uk/xmlui/handle/123456789/7775
Adegun OKU, Abdelghani A, Fortune F(2014). Oral manifestation of plantar-palmar fibromatosis. BMJ case reports vol. 2014,
10.1136/bcr-2014-204962
Adegun OK, Zou L, Willis A, Fortune F(2013). Facial biometrics: a novel technique for evaluation of morphological changes in orofacial Crohn's disease. BMJ case reports vol. 2013,
Adegun OK, Zou L, Willis A, Fortune F(2013). Facial biometrics: a novel technique for evaluation of morphological changes in orofacial Crohn's disease. BMJ Case Rep vol. 2013,
10.1136/bcr-2013-010460
Needleman I, Ashley P, Petrie A, Fortune F, Turner W, Jones J, Niggli J, Engebretsen L et al.(2013). Oral health and impact on performance of athletes participating in the London 2012 Olympic Games: a cross-sectional study. Br J Sports Med vol. 47, (16) 1054-1058.
10.1136/bjsports-2013-092891
https://qmro.qmul.ac.uk/xmlui/handle/123456789/14894
Adegun OK, Tomlins PH, Hagi-Pavli E, Bader DL, Fortune F(2013). Quantitative optical coherence tomography of fluid-filled oral mucosal lesions. Lasers Med Sci vol. 28, (5) 1249-1255.
10.1007/s10103-012-1208-y
Murray-Brown W, Croia C, Sutcliffe N, Tappuni A, Vartoukian S, Fortune F, Pitzalis C, Bombardieri M(2013). LESIONAL IL-21 EXPRESSION CORRELATES WITH FUNCTIONAL GERMINAL CENTER FORMATION AND T FOLLICULAR HELPER CELL INFILTRATION IN THE SALIVARY GLANDS OF SJOGREN'S SYNDROME. ANNALS OF THE RHEUMATIC DISEASES vol. 72, 77-77.
Tsang SM, Brown L, Gadmor H, Gammon L, Fortune F, Wheeler A, Wan H(2012). Desmoglein 3 acting as an upstream regulator of Rho GTPases, Rac-1/Cdc42 in the regulation of actin organisation and dynamics. Exp Cell Res vol. 318, (18) 2269-2283.
10.1016/j.yexcr.2012.07.002
Quax RAM, van Laar JAM, van Heerebeek R, Greiner K, Ben-Chetrit E, Stanford M, Wallace GR, Fortune F et al.(2012). Glucocorticoid sensitivity in Behçet's disease. Endocr Connect vol. 1, (2) 103-111.
10.1530/EC-12-0056
https://qmro.qmul.ac.uk/xmlui/handle/123456789/14896
Murray-Brown W, Croia C, Sutcliffe N, Tappuni A, Vartoukian S, Fortune F, Pitzalis C, Bombardieri M (2012). Lesional IL-21 expression correlates with functional germinal center formation and T follicular helper cell infiltration in the salivary glands of Sjogren's syndrome. IMMUNOLOGY. vol. 137, 491-491.
Pitiyage GN, Lim KP, Gemenitzidis E, Teh M-T, Waseem A, Prime SS, Tilakaratne WM, Fortune F et al.(2012). Increased secretion of tissue inhibitors of metalloproteinases 1 and 2 (TIMPs -1 and -2) in fibroblasts are early indicators of oral sub-mucous fibrosis and ageing. J Oral Pathol Med vol. 41, (6) 454-462.
10.1111/j.1600-0714.2012.01129.x
Dignan FL, Scarisbrick JJ, Cornish J, Clark A, Amrolia P, Jackson G, Mahendra P, Taylor PC et al.(2012). Organ-specific management and supportive care in chronic graft-versus-host disease. Br J Haematol vol. 158, (1) 62-78.
10.1111/j.1365-2141.2012.09131.x
Adegun OK, Tomlins PH, Hagi-Pavli E, McKenzie G, Piper K, Bader DL, Fortune F(2012). Quantitative analysis of optical coherence tomography and histopathology images of normal and dysplastic oral mucosal tissues. Lasers Med Sci vol. 27, (4) 795-804.
10.1007/s10103-011-0975-1
Murray-Brown W, Priori R, Tappuni T, Vartoukian S, Seoudi N, Picarelli G, Fortune F, Valesini G et al. (2012). MONOCYTE-DERIVED IL-32 EXPRESSION CORRELATES WITH THE LEVEL OF INFLAMMATION IN SALIVARY GLANDS OF SJOGREN'S SYNDROME. RHEUMATOLOGY. vol. 51, 176-176.
Tsang SM, Brown L, Lin K, Liu L, Piper K, O'Toole EA, Grose R, Hart IR et al.(2012). Non-junctional human desmoglein 3 acts as an upstream regulator of Src in E-cadherin adhesion, a pathway possibly involved in the pathogenesis of pemphigus vulgaris. J Pathol vol. 227, (1) 81-93.
10.1002/path.3982
Macey M, Hagi-Pavli E, Stewart J, Wallace GR, Stanford M, Shirlaw P, Fortune F(2011). Age, gender and disease-related platelet and neutrophil activation ex vivo in whole blood samples from patients with Behçet's disease. Rheumatology (Oxford) vol. 50, (10) 1849-1859.
10.1093/rheumatology/ker177
Aggarwal VR, Palmer NO, Nelson P, Ladwa R, Fortune F(2011). Proposed career pathway for clinical academic general dental practitioners. Prim Dent Care vol. 18, (4) 155-160.
10.1308/135576111797512757
Durrani O, Banahan K, Sheedy FJ, McBride L, Ben-Chetrit E, Greiner K, Vaughan RW, Kondeatis E et al.(2011). TIRAP Ser180Leu polymorphism is associated with Behcet's disease. Rheumatology (Oxford) vol. 50, (10) 1760-1765.
10.1093/rheumatology/ker200
Mannan T, Jing S, Foroushania SH, Fortune F, Wan H(2011). RNAi-mediated inhibition of the desmosomal cadherin (desmoglein 3) impairs epithelial cell proliferation. CELL PROLIFERAT vol. 44, (4) 301-310.
10.1111/j.1365-2184.2011.00765.x
Kerr AR, Warnakulasuriya S, Mighell AJ, Dietrich T, Nasser M, Rimal J, Jalil A, Bornstein MM et al.(2011). A systematic review of medical interventions for oral submucous fibrosis and future research opportunities. ORAL DIS vol. 17, 42-57.
10.1111/j.1601-0825.2011.01791.x
Pitiyage GN, Slijepcevic P, Gabrani A, Chianea YG, Lim KP, Prime SS, Tilakaratne WM, Fortune F et al.(2011). Senescent mesenchymal cells accumulate in human fibrosis by a telomere-independent mechanism and ameliorate fibrosis through matrix metalloproteinases. J Pathol vol. 223, (5) 604-617.
10.1002/path.2839
Moutasim KA, Jenei V, Sapienza K, Marsh D, Weinreb PH, Violette SM, Lewis MP, Marshall JF et al.(2011). Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis. J Pathol vol. 223, (3) 366-377.
10.1002/path.2786
Teh M-T, Parkinson EK, Thurlow JK, Liu F, Fortune F, Wan H(2011). A molecular study of desmosomes identifies a desmoglein isoform switch in head and neck squamous cell carcinoma. J Oral Pathol Med vol. 40, (1) 67-76.
10.1111/j.1600-0714.2010.00951.x
Tomlins PH, Adegun O, Hagi-Pavli E, Piper K, Bader D, Fortune F(2010). Scattering attenuation microscopy of oral epithelial dysplasia. Journal of Biomedical Optics vol. 15, (6) Article 066003,
10.1117/1.3505019
Bernabé E, Marcenes W, Mather J, Phillips C, Fortune F(2010). Impact of Behçet's syndrome on health-related quality of life: influence of the type and number of symptoms. Rheumatology (Oxford) vol. 49, (11) 2165-2171.
10.1093/rheumatology/keq251
Moutasim KA, Jenei V, Sapienza K, Marsh D, Weinreb PH, Violette SM, Lewis MP, Marshall JF et al.(2010). Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis. J Pathol
10.1002/path.2786
Moutasim KA, Jenei V, Sapienza K, Marsh D, Marshall J, Fortune F, Tilakaratne WM, Hart IR et al.(2010). Alkaloid-dependent upregulation of AlphavBeta6 integrin promotes oral submucous fibrosis. ORAL DIS vol. 16, (6) 528-528.
Abdelghani A, Tappuni A, Begum S, Makdissi J, Fortune F, Buchanan JAG(2010). An unusual location for a salivary gland stone. ORAL DIS vol. 16, (6) 564-564.
Bernabe E, Marcenes W, Mather J, Phillips C, Fortune F(2010). Impact of Behcet's Syndrome on quality of life. ORAL DIS vol. 16, (6) 545-545.
Begum SS, Tappuni AI, Abdelghani A, Seoudi N, Buchanan JAGB, Fortune F(2010). Linear naevus sebaceous syndrome (LNSS). ORAL DIS vol. 16, (6) 563-563.
Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C, Le JM, Yang B et al.(2010). Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease. Nat Genet vol. 42, (8) 698-702.
10.1038/ng.625
https://qmro.qmul.ac.uk/xmlui/handle/123456789/15000
Hagi-Pavli E, Macey M, Stewart J, Wallace G, Stanford M, Shirlaw P, Fortune F(2010). AGE, GENDER AND DISEASE RELATED PLATELET AND NEUTROPHIL ACTIVATION IN BEHCET'S. CLIN EXP RHEUMATOL vol. 28, (4) S128-S128.
10.1093/rheumatology/ker177
Waseem A, Ali M, Odell EW, Fortune F, Teh M-T(2010). Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma. Oral Oncol vol. 46, (7) 536-542.
10.1016/j.oraloncology.2010.03.022
https://qmro.qmul.ac.uk/xmlui/handle/123456789/1099
Bergmeier LA, Adegun O, Seoudi N, Hamedi M, Hagi-Pavli E, Fortune F(2010). INDUCIBLE HUMAN HEAT SHOCK PROTEIN (HSP70) IS ELEVATED IN THE SALIVA OF BEHCET'S PATIENTS. CLIN EXP RHEUMATOL vol. 28, (4) S123-S123.
Hagi-Pavli E, Novak T, Bergmeier L, Seoudi N, Moeinian M, Fortune F(2010). PLASMA AND SALIVA CYTOKINE PROFILES IN BEHCET'S DISEASE: DO CYTOKINE LEVELS IN PLASMA CORRELATE WITH LEVELS IN SALIVA?. CLIN EXP RHEUMATOL vol. 28, (4) S129-S129.
Hagi-Pavli E, Bergmeier L, Khan I, Seoudi N, Fortune F(2010). SECRETORY LEUKOCYTE PROTEASE INHIBITOR (SLPI) IN BEHCET'S PATIENTS SALIVA. CLIN EXP RHEUMATOL vol. 28, (4) S128-S128.
Mather J, Marcenes W, Bernabe E, Phillips C, Fortune F(2010). SYMPTOMS OF BEHCET'S SYNDROME IN A REPRESENTATIVE GROUP OF ADULTS IN THE UK. CLIN EXP RHEUMATOL vol. 28, (4) S127-S127.
Seoudi N, Hagi-Pavli E, Bergmeier L, Stewart J, Curtis M, Fortune F(2010). THE ORAL HEALTH AND MICROBIOTA OF UK BEHCET'S DISEASE PATIENTS. CLIN EXP RHEUMATOL vol. 28, (4) S124-S124.
Tsang S, Liu L, Teh M, Wheeler A, Piper K, Grose R, Hart I, Garrod D et al. (2010). Novel role for human desmoglein 3 in regulating E-cadherin mediated adherens junctions through Src family kinase activation. JOURNAL OF INVESTIGATIVE DERMATOLOGY. vol. 130, S33-S33.
Tsang SM, Liu L, Teh M-T, Wheeler A, Grose R, Hart IR, Garrod DR, Fortune F et al.(2010). Desmoglein 3, via an interaction with E-cadherin, is associated with activation of Src. PloS ONE vol. 5, (12)
10.1371/journal.pone.0014211
https://qmro.qmul.ac.uk/xmlui/handle/123456789/11130
Nunn H, Lalli A, Fortune F, Croucher R(2009). Oral cancer screening in the Bangladeshi community of Tower Hamlets: a social model. Br J Cancer vol. 101 Suppl 2, S68-S72.
10.1038/sj.bjc.6605394
https://qmro.qmul.ac.uk/xmlui/handle/123456789/14901
Kappen JH, Wallace GR, Stolk L, Rivadeneira F, Uitterlinden AG, van Daele PLA, Laman JD, Kuijpers RWAM et al.(2009). Low prevalence of NOD2 SNPs in Behçet's disease suggests protective association in Caucasians. Rheumatology (Oxford) vol. 48, (11) 1375-1377.
10.1093/rheumatology/kep292
Mumcu G, Niazi S, Stewart J, Hagi-Pavli E, Gokani B, Seoudi N, Ergun T, Yavuz S et al.(2009). Oral health and related quality of life status in patients from UK and Turkey: a comparative study in Behcet's disease. J ORAL PATHOL MED vol. 38, (5) 406-409.
10.1111/j.1600-0714.2009.00752.x
Dalghous AM, Elkhabuli JO, Fortune F(2009). Behçet's disease-a delay in diagnosis: Why look in the mouth?. Oral Surgery vol. 2, (1) 44-46.
10.1111/j.1752-248X.2009.01030.x
Gemenetzidis E, Bose A, Riaz AM, Chaplin T, Young BD, Ali M, Sugden D, Thurlow JK et al.(2009). FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation. PLoS One vol. 4, (3)
10.1371/journal.pone.0004849
https://qmro.qmul.ac.uk/xmlui/handle/123456789/11131
Curnow SJ, Pryce K, Modi N, Knight B, Graham EM, Stewart JE, Fortune F, Stanford MR et al.(2008). Serum cytokine profiles in Behcet's disease: Is there a role for IL-15 in pathogenesis?. IMMUNOL LETT vol. 121, (1) 7-12.
10.1016/j.imlet.2008.07.009
Teh MT, Tilakaratne WM, Chaplin T, Young BD, Ariyawardana A, Pitiyage G, Lalli A, Stewart JE et al.(2008). Fingerprinting genomic instability in oral submucous fibrosis. J Oral Pathol Med vol. 37, (7) 430-436.
10.1111/j.1600-0714.2008.00643.x
Wallace GR, Murray PI, Fortune F, Kanawati C, Madanat W, Vaughan R, Kondeatis E, Stanford MR(2008). AUTOIMMUNE GENETIC MASTERSWITCHES IN BEHCET'S DISEASE: AUTOIMMUNITY OR AUTOINFLAMMATION. CLIN EXP RHEUMATOL vol. 26, (4) S15-S15.
Shafi S, Stanford MR, Fortune F, Graham EM, Wallace GR, Hayday AC(2008). CIRCULATING LYMPHOCYTES IN BEHCET'S DISEASE. CLIN EXP RHEUMATOL vol. 26, (4) S13-S13.
Bye L, Modi N, Stanford MR, Kondeatis E, Vaughan R, Fortune F, Kanawati C, Ben-Chetrit E et al.(2008). CTLA-4 polymorphisms are not associated with ocular inflammatory disease. Tissue Antigens vol. 72, (1) 49-53.
10.1111/j.1399-0039.2008.01062.x
Stewart JE, Mumcu G, Haque A, Hagi-Pavli E, Freysdot J, Direskeneli H, Shirlaw P, Wallace G et al.(2008). DIFFERENTIAL CYTOKINE EXPRESSION BY PBMC'S OF BEHCET'S PATIENTS: INFLUENCE OF SERUM AND SALIVA. CLIN EXP RHEUMATOL vol. 26, (4) S9-S9.
Hagi-Pavli E, Plequezuelos O, Seoudi N, Stewart JE, Shirlaw P, Wallace G, Stanford MR, Fortune F(2008). EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTOR AND ITS LIGANDS IN THE ORAL CAVITY OF BEHCET'S DISEASE PATIENTS. CLIN EXP RHEUMATOL vol. 26, (4) S9-S10.
Kappen JH, van Laar JAM, Stolk LB, Uitterlinden AG, van Daele PLA, Stanford MR, Fortune F, Wallace GR et al.(2008). NOD2 (CARD15) SINGLE NUCLEOTIDE POLYMORPHISMS PROTECTIVE IN BEHCET'S DISEASE. CLIN EXP RHEUMATOL vol. 26, (4) S14-S14.
Mumcu G, Stewart J, Hagi-Pavli E, Gokani B, Seoudi N, Ergun T, Yavuz S, Stanford MR et al.(2008). ORAL HEALTH AND QUALITY OF LIFE STATUS IN PATIENTS FROM UK AND TURKEY: A COMPARATIVE STUDY IN BEHCET'S DISEASE. CLIN EXP RHEUMATOL vol. 26, (4) S5-S6.
10.1111/j.1600-0714.2009.00752.x
Tilakaratne WM, Iqbal Z, Teh MT, Ariyawardana A, Pitiyage G, Cruchley A, Stewart JE, Hagi-Pavli E et al.(2008). Upregulation of HIF-1alpha in malignant transformation of oral submucous fibrosis. J Oral Pathol Med vol. 37, (6) 372-377.
10.1111/j.1600-0714.2007.00625.x
Fortune F, Fortune A, Kelly K, Sargent J, McGuckin S, Quinn F, Haslam K, O'Brien D et al. (2008). T-CELL LARGE GRANULAR LYMPHOCYTE LEUKAEMIA: CLINICAL COURSE AND RESPONSE TO TREATMENT. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. vol. 93, 104-104.
Lalli A, Tilakaratne WM, Ariyawardana A, Fitchett C, Leigh IM, Hagi-Pavli E, Cruchley AT, Parkinson EK et al.(2008). An altered keratinocyte phenotype in oral submucous fibrosis: correlation of keratin K17 expression with disease severity. J Oral Pathol Med vol. 37, (4) 211-220.
10.1111/j.1600-0714.2007.00609.x
Tilakaratne WM, Freysdottir J, Fortune F(2008). Orofacial granulomatosis: review on aetiology and pathogenesis. J ORAL PATHOL MED vol. 37, (4) 191-195.
10.1111/j.1600-0714.2007.00591.x
Kose O, Stewart J, Waseem A, Lalli A, Fortune F(2008). Expression of cytokeratins, adhesion and activation molecules in oral ulcers of Behçet's disease. Clin Exp Dermatol vol. 33, (1) 62-69.
10.1111/j.1365-2230.2007.02558.x
Harper LJ, Piper K, Common J, Fortune F, Mackenzie IC(2007). Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma. J Oral Pathol Med vol. 36, (10) 594-603.
10.1111/j.1600-0714.2007.00617.x
Baranathan V, Stanford MR, Vaughan RW, Kondeatis E, Graham E, Fortune F, Madanat W, Kanawati C et al.(2007). The association of the PTPN22 620W polymorphism with Behcet's disease. ANN RHEUM DIS vol. 66, (11) 1531-1533.
10.1136/ard.2007.073866
Summers SA, Tilakaratne WM, Fortune F, Ashman N(2007). Renal disease and the mouth. Am J Med vol. 120, (7) 568-573.
10.1016/j.amjmed.2006.12.007
Bye L, Modi N, Stanford M, Kondeatis E, Vaughan R, Fortune F, Madanat W, Kanawati C et al.(2007). CTLA-4 gene polymorphisms 49A/G and-318C/T do not associate with Behcet's disease. INFLAMM RES vol. 56, S405-S405.
Tilakaratne W, Iqball Z, Teh MT, Ariyawardana A, Pitiyage G, Cruchley A, Hagi-Pavli E, Lalli A et al. (2007). Up regulation of HIF-1 alpha in the progression and malignant transformation of oral submucous fibrosis. ORAL ONCOLOGY. vol. 2, 204-205.
Freysdottir J, Zhang S, Tilakaratne WM, Fortune F(2007). Oral biopsies from patients with orofacial granulomatosis with histology resembling Crohn's disease have a prominent Th1 environment. Inflamm Bowel Dis vol. 13, (4) 439-445.
10.1002/ibd.20023
Hagi-Pavli E, Pleguezuelos O, Fazil BI, Stewart JE, Fortune F (2007). Delayed healing of recurrent aphthous ulceration in Behcet's disease patients. IMMUNOLOGY. vol. 120, 53-53.
Wallace GR, Kondeatis E, Vaughan RW, Verity DH, Chen Y, Fortune F, Madanat W, Kanawati CA et al.(2007). IL-10 genotype analysis in patients with Behçet's disease. Hum Immunol vol. 68, (2) 122-127.
10.1016/j.humimm.2006.11.010
Freysdottir J, Hussain L, Farmer I, Lau SH, Fortune F(2006). Diversity of gamma delta T cells in patients with Behcet's disease is indicative of polyclonal activation. ORAL DIS vol. 12, (3) 271-277.
10.1111/j.1601-0825.2005.01185.x
Dalghous AM, Freysdottir J, Fortune F(2006). Expression of cytokines, chemokines, and chemokine receptors in oral ulcers of patients with Behcet's disease (BD) and recurrent aphthous stomatitis is Th1-associated, although Th2-association is also observed in patients with BD. SCAND J RHEUMATOL vol. 35, (6) 472-475.
10.1080/03009740600905380
Stewart JE, Mumcu G, Curnow J, Wallace G, Stanford M, Fortune F(2005). Saliva: contribution to inflammatory status in Bechet's disease. IMMUNOLOGY vol. 116, 85-85.
Wallace GR, Durrani O, Curnow J, Williams H, Hamburger J, Fortune F, Vaughan R, Murray PI(2005). Toll-like receptor (TLR) expression in mouth ulcer biopsies from patients with Behcet's disease. INFLAMM RES vol. 54, S190-S190.
Yang X, Ahmad T, Gogus F, Wallace GR, Madanat W, Kanawati CA, Stanford MR, Fortune F et al.(2005). Analysis of the CC chemokine receptor 5 (CCR5)Delta 32 polymorphism in Behcet's disease (vol 31, pg 11, 2004). INT J IMMUNOGENET vol. 32, (3) 219-219.
Yang X, Ahmad T, Gogus F, Verity D, Wallace GR, Madanat W, Kanawati CA, Stanford MR et al.(2005). Erratum: Analysis of the CC chemokine receptor 5 (CCR5)Δ32 polymorphism in Behçet's disease (International Journal of Imunogenetics (2004) 31(11)). International Journal of Immunogenetics vol. 32, (3)
10.1111/j.1744-313X.2005.00513.x
Ahmad T, Zhang L, Gogus F, Verity D, Wallace G, Madanat W, Fayyad F, James T et al.(2005). CARD15 polymorphisms in Behçet's disease. Scand J Rheumatol vol. 34, (3) 233-237.
10.1080/03009740510018714
Nessim M, Sivaraj RR, Young SP, Fortune F, Stanford MR, Murray PI, Wallace GR (2005). Metabonomic analysis of serum from patients with Behcet's disease: A new research tool?. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. vol. 46,
Wallace GR, Pryce KM, Curnow SJ, Fortune F, Stewart JE, Modi N, Knight B, Stanford MR et al. (2005). Multiplex bead analysis of cytokines in serum from patients with Behcet's disease. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. vol. 46,
Murray PI, Durrani OM, Hamburger J, Williams H, Fortune F, Stewart J, Wallace GR (2005). Toll-like receptor (TLR) expression in oral ulcer biopsies from Behcet's disease (BD) patients: A role for the innate immune system. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. vol. 46,
Yang X, Ahmad T, Gogus F, Verity D, Wallace GR, Madanat W, Kanawati CA, Stanford MR et al.(2004). Analysis of the CC chemokine receptor 5 (CCR5) Delta32 polymorphism in Behçet's disease. Eur J Immunogenet vol. 31, (1) 11-14.
10.1111/j.1365-2370.2004.00444.x
Chen Y, Vaughan RW, Kondeatis E, Fortune F, Graham EM, Stanford MR, Wallace GR(2004). Chemokine gene polymorphisms associate with gender in patients with uveitis. TISSUE ANTIGENS vol. 63, (1) 41-45.
10.1111/j.1399-0039.2004.00150.x
FORTUNE F(2004). Human Disease For Dentistry. Oxford University Press (Oxford),
Stark P, Fortune F(2003). Teaching clinical skills in developing countries: are clinical skills centres the answer?. Educ Health (Abingdon) vol. 16, (3) 298-306.
10.1080/13576280310001607433
Chen Y, Stanford MR, Wallace GR, Vaughan RW, Kondeatis E, Fortune F(2003). Factor V Leiden mutation does not correlate with retinal vascular occlusion in white patients with Behçet's disease. Br J Ophthalmol vol. 87, (8) 1048-1049.
10.1136/bjo.87.8.1048
Chen Y, Vaughan R, Kondeatis E, Graham EM, Fortune F, Wallace GR, Stanford MR (2003). Altered distribution of Polymorphisms in the promoter gene for IL-10 in patients with Behcet's disease but not those with idiopathic retinal vasculitis. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. vol. 44, U607-U607.
Ahmad T, Zhang LN, Gogus F, Wallace G, Yang XS, Madanat W, James T, Neville M et al. (2003). NOD2/CARD15: a genetic link between Behcet's disease (BD) and Crohn's disease (CD)?. GASTROENTEROLOGY. vol. 124, A373-A373.
10.1016/S0016-5085(03)81885-1
Ahmad T, Wallace GR, James T, Neville M, Bunce M, Mulcahy-Hawes K, Armuzzi A, Crawshaw J et al.(2003). Mapping the HLA association in Behçet's disease: a role for tumor necrosis factor polymorphisms?. Arthritis Rheum vol. 48, (3) 807-813.
10.1002/art.10815
Fortune F(2003). Can you catch Behçet's disease?. J Lab Clin Med vol. 141, (1) 5-6.
10.1067/mlc.2003.2
Ahmad T, Wallace G, James T, Bunce M, Mulcahy-Hawes K, Armuzzi A, Fortune F, Stanford M et al.(2002). Behcet or Crohn disease? Combination HLA-B*51 and CARD15 molecular typing may help decide. GASTROENTEROLOGY vol. 122, (4) A301-A301.
Ahmad T, Wallace G, James T, Bunce M, Mulcahy-Hawes K, Armuzzi A, Fortune F, Stanford M et al.(2002). Behcet's disease and TNF: A missing genetic link?. GUT vol. 50, A14-A15.
Ahmad T, Wallace G, James T, Bunce M, Mulcahy-Hawes K, Armuzzi A, Fortune F, Stanford M et al.(2002). Behcet's or Crohn's disease? Combination HLA-B*51 and NOD2 molecular typing may help decide. GUT vol. 50, A15-A15.
Ahmad T, Wallace G, James T, Bunce M, Mulcahy-Hawes K, Armuzzi A, Fortune F, Stanford M et al.(2002). Behcets disease and TNF: A missing genetic link?. GASTROENTEROLOGY vol. 122, (4) A300-A300.
Farmer I, Freysdottir J, Dalghous AM, Fortune F(2001). Expression of adhesion and activation molecules in human buccal epithelial cell lines and normal human buccal epithelium in situ. J Oral Pathol Med vol. 30, (2) 113-120.
10.1034/j.1600-0714.2001.300208.x
Freysdottir J, Lau SH, Fortune F(1999). γδ T cells in Behcet's disease (BD) and recurrent aphthous stomatitis (RAS). Clinical and Experimental Immunology vol. 118, (3) 451-457.
10.1046/j.1365-2249.1999.01069.x
Freysdottir J, Hussain L, Farmer I, Lau SH, Fortune F (1999). gamma delta usage in patients with Bechet's disease. JOURNAL OF DENTAL RESEARCH. vol. 78, 1080-1080.
Sanderson JD, Barnard K, Shirlaw P, Odell E, Chinyama C, Fortune F, Freysdottir J, Twitchen M et al. (1999). The oral and intestinal features of oro-facial granulomatosis. GASTROENTEROLOGY. vol. 116, A811-A811.
Carpenter GH, Fortune F, Freysdottir J, Proctor GB(1998). Characterising lectin binding to the O-linked sugars of immunoglobulin A1. Biochemical Society Transactions vol. 26, (4)
10.1042/bst026s384
Buchanan JAG, Morris A, Fortune F(1997). A mechanic who coughed up blood for 15 months. Lancet vol. 349, (9070)
10.1016/s0140-6736(97)05077-0
Twitchen MJ, Freysdottir J, Fortune F (1997). Laser therapy, polycystic ovary syndrome and enlarged salivary glands. JOURNAL OF DENTAL RESEARCH. vol. 76, 1078-1078.
Freysdottir J, Twitchen MJ, Fortune F (1997). Recurrent oral ulceration - The role of gamma delta T cells. JOURNAL OF DENTAL RESEARCH. vol. 76, 1078-1078.
Warr K, Fortune F, Namie S, Wilson A, Shinnick T, Van Der Zee R, Williams G, Lehner T(1997). T-cell epitopes recognized within the 65 000 MW hsp in patients with IgA nephropathy. Immunology vol. 91, (3) 399-405.
10.1046/j.1365-2567.1997.00279.x
Hasan A, Fortune F, Wilson A, Lehner T(1996). Role of gamma delta T cells in Behcet's disease - Reply. LANCET vol. 347, (9015) 1632-1632.
Hasan A, Fortune F, Wilson A, Warr K, Shinnick T, Mizushima Y, Van Der Zee R, Stanford MR et al.(1996). Role of γδ T cells in pathogenesis and diagnosis of Behçet's disease. Lancet vol. 347, (9004) 789-794.
10.1016/S0140-6736(96)90868-5
Direskeneli H, Hasan A, Shinnick T, Mizushima Y, Van Der Zee R, Fortune F, Stanford MR, Lehner T(1996). Recognition of B-Cell Epitopes of the 65 kDa HSP in Behçet's Disease. Scandinavian Journal of Immunology vol. 43, (4) 464-471.
10.1046/j.1365-3083.1996.d01-53.x
Gaston JSH, Hasan A, Fortune F, Wilson A, Lehner T(1996). Role of γδ T cells in Behcet's disease [16]. Lancet vol. 347, (9015) 1631-1632.
10.1016/S0140-6736(96)91121-6
Fortune F, Hasan A, Wilson A, Warrik K, Lehner T (1996). Stress proteins and their role in the immunoregulation and diagnosis of Behcet's disease. JOURNAL OF DENTAL RESEARCH. vol. 75, 3338-3338.
WARR KJ, FORTUNE F, NAMIE S, WILSON A, WILLIAMS DG, LEHNER T (1995). EPITOPE MAPPING WITH 65KD HEAT-SHOCK PROTEIN IN IGA NEPHROPATHY. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. vol. 6, 857-857.
Buchanan JAG, Hasan AS, Churchill L, Fortune F(1995). Atypical palatal ulceration. Postgraduate Medical Journal vol. 71, (831) 55-56.
10.1136/pgmj.71.831.55
Rudd P, Fortune F, Lehner T, Parekh R, Patel T, Wormald M, Malhotra R, Sim R et al.(1995). Lectin-carbohydrate interactions in disease: T-cell recognition of IgA and IgD; mannose binding protein recognition of IgG0. Advances in Experimental Medicine and Biology vol. 376, 147-152.
WARR K, FORTUNE F, NAIME S, WILLIAMS DG, LEHNER T (1994). T-CELL EPITOPE MAPPING IN IGA NEPHROPATHY. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. vol. 5, 773-773.
Rudd PM, Fortune F, Patel T, Parekh RB, Dwek RA, Lehner T(1994). A human T-cell receptor recognizes 'O'-linked sugars from the hinge region of human IgA1 and IgD. Immunology vol. 83, (1) 99-106.
Buchanan JAG, Fortune F(1994). Bilateral parotid enlargement as a presenting feature of bulimia nervosa in a post-adolescent male. Postgraduate Medical Journal vol. 70, (819) 27-30.
10.1136/pgmj.70.819.27
FORTUNE F, WALKER J, LEFRANCOIS M, LEHNER T(1994). The Expression of Carbohydrate Antigens in Activated T Cells and in Autoimmune Diseases. Scandinavian Journal of Immunology vol. 40, (6) 636-642.
10.1111/j.1365-3083.1994.tb03516.x
Fortune F, Lehner T(1993). P 131 T cells expressing γδ receptors and cytophilic IgA1 antibodies in Behçet's disease. La Revue de medecine interne vol. 14, (SUPPL. 1)
Fortune F, Buchanan JAG(1993). Oral lichen planus and coeliac disease. The Lancet vol. 341, (8853) 1154-1155.
10.1016/0140-6736(93)93175-Z
McMillan ND, Fortune F, Finlayson O, McMillan DDG, Townsend D, Daly D, Fingleton M, Dalton M(1992). A fiber drop analyzer: A new analytical instrument for the individual, sequential, or collective measurement of the physical and chemical properties of liquids. Review of Scientific Instruments vol. 63, (6) 3431-3454.
10.1063/1.1143748
McMillan ND, Finlayson O, Fortune F, Fingleton M, Daly D, Townsend D, McMillan DDG, Dalton MJ(1992). The fibre drop analyser: A new multianalyser analytical instrument with applications in sugar processing and for the analysis of pure liquids. Measurement Science and Technology vol. 3, (8) 746-764.
10.1088/0957-0233/3/8/012
FORTUNE F, COURTEAU M, WILLIAMS DG, LEHNER T(1992). T-CELL AND B-CELL RESPONSES FOLLOWING IMMUNIZATION WITH TETANUS TOXOID IN IGA NEPHROPATHY. CLINICAL AND EXPERIMENTAL IMMUNOLOGY vol. 88, (1) 62-67.
FORTUNE F, COURTEAU M, WILLIAMS DG, LEHNER T(1992). T and B cell responses following immunization with tetanus toxoid in IgA nephropathy. Clinical & Experimental Immunology vol. 88, (1) 62-67.
10.1111/j.1365-2249.1992.tb03040.x
LEHNER T, FORTUNE F, LAVERY E, STUDD M (1991). RECENT ADVANCES IN T-CELL IMMUNOREGULATION AND IN THE MICROBIAL CAUSES OF BEHCETS-DISEASE. BEHCETS DISEASE. vol. 8, 463-473.
Fortune F, Kingston J, Barnes CS, Lehner T(1990). Identification and characterization of IgA and Vicia villosa-binding T cell subsets in rheumatoid arthritis. Clinical and Experimental Immunology vol. 79, (2) 202-208.
10.1111/j.1365-2249.1990.tb05179.x
Fortune F, Walker J, Lehner T(1990). The expression of γδ T cell receptor and the prevalence of primed, activated and IgA-bound T cells in Behcet's syndrome. Clinical and Experimental Immunology vol. 82, (2) 326-332.
10.1111/j.1365-2249.1990.tb05447.x
Fortune F, Lehner T(1988). Phenotypic expression of Vicia villosa binding T cell subsets, as markers of contrasuppressor cells in systemic lupus erythematosus. Clinical and Experimental Immunology vol. 74, (1) 100-104.
Fellowes R, Fortune F, Bergmeier LA, Lehner T(1988). The effect of immunization with a 14‐kda streptococcal antigen on primate t cell and b cell responses. European Journal of Immunology vol. 18, (4) 559-564.
10.1002/eji.1830180411
FORTUNE F (1987). A DOUBLE IMMUNOFLUORESCENCE CYTOFLUOROMETRIC INVESTIGATION OF SUBSETS OF T-CELLS IN AUTOIMMUNE-DISEASES. JOURNAL OF DENTAL RESEARCH. vol. 66, 835-835.
Symons C, Fortune F, Greenbaum RA, Dandona P(1985). Cardiac hypertrophy, hypertrophic cardiomyopathy, and hyperparathyroidism - an association. British Heart Journal vol. 54, (5) 539-542.
10.1136/hrt.54.5.539
FORTUNE F, GREENBAUM RA, DANDONA P, SYMONS C (1985). CARDIAC-HYPERTROPHY, HYPERTROPHIC CARDIOMYOPATHY AND HYPERPARATHYROIDISM - AN ASSOCIATION. BRITISH HEART JOURNAL. vol. 53, 112-113.
Return to top